|
Hello: Please take a moment and answer the short survey on drug development. Your participation in this study is completely voluntary. It will take approximately 5-10 minutes to complete the questionnaire.
Your answers will help our clients better serve the industry and will be kept confidential. You will be given a chance to enter the drawing at the end of the survey. This is optional. Thank you for your time and consideration.
Please start with the survey now by clicking on the Continue button below.
|
| |
|
|
|
Please select the level of screening that most closely defines your group's or your institution's strategy surrounding Polymorph Screening |
| |
| |
|
|
|
We routinely search for co-crystals as part of our solid form development program |
| |
| |
|
|
|
When considering outsourcing solid-state development (polymorph, salt, co-crystal, etc) our institution would consider (check all that apply) |
| |
|
| |
|
|
|
I would classify my insitution as: |
| |
| |
|
|
|
I would expect to pay X$ for a preliminary (early) polymorph screen: |
| |
| |
|
|
|
| How many solid-state development projects do you or your institution outsource yearly? | | |
|
|
|
|
How many conditions (or experiments) do you feel are necessary to conduct a thorough polymorph screen whereby you have a reasonable degree of confidence you have found most relevant forms? |
| |
| |
|
|
|
I believe high-throughput (HT) solvent-based screening is the best method for finding all relevant solid forms. Please select the statement THAT MOST CLOSELY MATCHES YOUR BELIEF |
| |
| |
|
|
|
* When we select a solid-state screening/selection vendor for polymorph, salt, or co-crystal work we do so by (rank in order of importance, 1 being most important, 6 being least important) |
| |
Corporate selects vendors for us |
| | Capacity, time line of execution |
| | Past experience |
| | Reputation |
| | Number/diversity of capabilites |
| | Price |
| |
| |
|
|
|
* I (or my insitution) need the most help with (rank in order of need, 1 being greatest need, 6 being least need) |
| |
Consistent API maufacturing under cGMP |
| | Routine analytical chemistry |
| | Amorphous material development |
| | Formulation Development / Excipient Compatibility |
| | Solid-state development (polymorph, salt, cocrystal) |
| | Lifecycle and IP management |
| |
| |
|
|
|
| I'd like to be entered into the drawing (please include name, institution, and phone below). If you do not wish to enter, simply do not answer this question. | | |
|
|
|